Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby et al., The Lancet, doi:10.1016/S0140-6736(22)00163-5 (preprint 6/16/2021)
https://c19early.org/recoveryr.html